DRUG · Mapped RxNorm record
Bicalutamide
Normalized identity: bicalutamideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer
NCT00814788
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Everolimus
Normalized identity: everolimusView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedBicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
BicalutamideDRUG · verified · RxNorm: bicalutamide
EverolimusDRUG · verified · RxNorm: everolimus
Sponsors & collaborators
University of California, Davislead sponsor
Novartiscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00814788 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.